Literature DB >> 20414752

Molecular monitoring of viral infections after hematopoietic stem cell transplantation.

Per Ljungman1.   

Abstract

Viral infections are important complications after allogeneic hematopoietic stem cell transplantation. Viral load monitoring combined with preemptive antiviral therapy has become an established strategy for the management of CMV infections. This review discusses and summarizes information regarding viral load monitoring for EBV, human herpesvirus 6, and adenoviruses including virological and clinical aspects. Standardized assays are lacking for these viruses and additional studies are needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414752     DOI: 10.1007/s12185-010-0570-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  61 in total

1.  Adenoviral infections in pediatric transplant recipients: a hospital-based study.

Authors:  Marcela Hernández de Mezerville; Raymond Tellier; Susan Richardson; Diane Hébert; John Doyle; Upton Allen
Journal:  Pediatr Infect Dis J       Date:  2006-09       Impact factor: 2.129

2.  Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.

Authors:  P Ljungman; R de la Camara; C Cordonnier; H Einsele; D Engelhard; P Reusser; J Styczynski; K Ward
Journal:  Bone Marrow Transplant       Date:  2008-06-30       Impact factor: 5.483

3.  Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

Authors:  A Gustafsson; V Levitsky; J Z Zou; T Frisan; T Dalianis; P Ljungman; O Ringden; J Winiarski; I Ernberg; M G Masucci
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

4.  The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.

Authors:  Mikael Sundin; Katarina Le Blanc; Olle Ringdén; Lisbeth Barkholt; Brigitta Omazic; Christina Lergin; Victor Levitsky; Mats Remberger
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

5.  Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease.

Authors:  Thomas Lion; Rosi Baumgartinger; Franz Watzinger; Susanne Matthes-Martin; Magdalena Suda; Sandra Preuner; Barbara Futterknecht; Anita Lawitschka; Christina Peters; Ulrike Potschger; Helmut Gadner
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

6.  Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles.

Authors:  Katherine N Ward; Hoe Nam Leong; Elisabeth P Nacheva; Julie Howard; Claire E Atkinson; Nicholas W S Davies; Paul D Griffiths; Duncan A Clark
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

7.  Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis.

Authors:  Duncan A Clark; Elisabeth P Nacheva; Hoe Nam Leong; Diana Brazma; Ying Ting Li; Edward H F Tsao; Hubertus C E Buyck; Claire E Atkinson; Heather M Lawson; Michael N Potter; Paul D Griffiths
Journal:  J Infect Dis       Date:  2006-02-22       Impact factor: 5.226

8.  Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.

Authors:  W W Seeley; F M Marty; T M Holmes; K Upchurch; R J Soiffer; J H Antin; L R Baden; E B Bromfield
Journal:  Neurology       Date:  2007-07-10       Impact factor: 9.910

9.  Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients.

Authors:  I Gustafson; A Lindblom; Z Yun; H Omar; L Engstrom; I Lewensohn-Fuchs; P Ljungman; K Broliden
Journal:  J Clin Virol       Date:  2008-06-11       Impact factor: 3.168

10.  Viral disease prevention after hematopoietic cell transplantation.

Authors:  J Zaia; L Baden; M J Boeckh; S Chakrabarti; H Einsele; P Ljungman; G B McDonald; H Hirsch
Journal:  Bone Marrow Transplant       Date:  2009-10       Impact factor: 5.483

View more
  18 in total

1.  Monitoring of Epstein-Barr virus load in patients after allogeneic hematopoietic stem cell transplantation.

Authors:  P Volfova; M Lengerova; J Winterova; Z Racil; D Dvorakova; J Mayer
Journal:  Infection       Date:  2012-04-19       Impact factor: 3.553

2.  Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography.

Authors:  Ryosuke Ueda; Shigeo Fuji; Shin-ichiro Mori; Nobuhiro Hiramoto; Hisayoshi Hashimoto; Takashi Tanaka; Kohei Tada; Yujin Kobayashi; Noriyuki Morikawa; Akihito Shinohara; Keiji Okinaka; Akiko M Maeshima; Saiko Kurosawa; Sung-Won Kim; Takuya Yamashita; Takahiro Fukuda
Journal:  Int J Hematol       Date:  2015-05-01       Impact factor: 2.490

3.  Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.

Authors:  Ramona Gilles; Marco Herling; Udo Holtick; Eva Heger; Sabine Awerkiew; Irina Fish; Konstantin Höller; Saleta Sierra; Elena Knops; Rolf Kaiser; Christof Scheid; Veronica Di Cristanziano
Journal:  Med Microbiol Immunol       Date:  2017-07-12       Impact factor: 3.402

4.  Comparative evaluation of three commercial quantitative cytomegalovirus standards by use of digital and real-time PCR.

Authors:  R T Hayden; Z Gu; S S Sam; Y Sun; L Tang; S Pounds; A M Caliendo
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

5.  A Comprehensive Statistical Framework for Determination of Commutability, Accuracy, and Agreement in Clinical DNAemia Assays.

Authors:  L Tang; Y Su; Z Gu; A M Caliendo; S Pounds; R T Hayden
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

6.  T-cell therapy for viral infections following transplantation: why stop at three viruses?

Authors:  John A Barrett
Journal:  Mol Ther       Date:  2012-08       Impact factor: 11.454

7.  Quantitative Assessment of Commutability for Clinical Viral Load Testing Using a Digital PCR-Based Reference Standard.

Authors:  L Tang; Y Sun; D Buelow; Z Gu; A M Caliendo; S Pounds; R T Hayden
Journal:  J Clin Microbiol       Date:  2016-04-13       Impact factor: 5.948

8.  Comparative Performance of Reagents and Platforms for Quantitation of Cytomegalovirus DNA by Digital PCR.

Authors:  R T Hayden; Z Gu; S S Sam; Y Sun; L Tang; S Pounds; A M Caliendo
Journal:  J Clin Microbiol       Date:  2016-08-17       Impact factor: 5.948

9.  Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus.

Authors:  R T Hayden; Z Gu; J Ingersoll; D Abdul-Ali; L Shi; S Pounds; A M Caliendo
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

10.  Epstein-Barr virus: general factors, virus-related diseases and measurement of viral load after transplant.

Authors:  Luciana Cristina Fagundes Gequelin; Irina N Riediger; Sueli M Nakatani; Alexander W Biondo; Carmem M Bonfim
Journal:  Rev Bras Hematol Hemoter       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.